Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Fermin Orgambide

54 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Novamind To Offer Virtual Mental Health Therapy Sessions

By Fermin Orgambide
Today, 5:31 PM
Novamind (OTCQB: NVMDF), which is to be acquired by Numinus Wellness (OTCMKTS: NUMIF), recently announced a collaboration with health coaching platform HealCommunit

NUMIF

Read More
2 minute read
  • Biotech
  • Cannabis
  • General
  • Markets
  • News
  • Psychedelics
  • Stock Split

Field Trip Health To Divide Into Two Separate Public Companies

By Fermin Orgambide
Today, 5:31 PM
Field Trip Health (NASDAQ: FTRP) will divide two of its divisions into public companies of their own.

FTRP

Read More
1 minute read
  • Biotech
  • Cannabis
  • General
  • Markets
  • News
  • Psychedelics

Biomind Begins Clinical Trial For Inhaled DMT Analog Substance To Treat Depression

By Fermin Orgambide
Today, 5:31 PM
Biomind Labs (OTCQB:BMNDF) has begun administering its proprietary second-generation psychedelic, BMND01, in a Phase 1/2a clinical trial for treatment-resistant depression (TRD).

BMNDF

Read More
1 minute read
  • Biotech
  • Cannabis
  • General
  • Markets
  • News
  • Psychedelics

Cybin’s Major Depressive Disorder Treatment Trials Continue With Clinilabs Drug Development Corp

By Fermin Orgambide
Today, 5:31 PM
Three weeks after announcing the results of its preclinical trials for CYB003, Cybin (NYSE:CYBN) made public a partnership with Clinilabs Drug Development Corporation to take the proprietary drug to it

CYBN

Read More
2 minute read
  • Cannabis
  • Events
  • Exclusives
  • Markets
  • News
  • Small Cap

EXCLUSIVE: Why The Future Of Cannabis Could Look A Lot Like CPG

By Fermin Orgambide
Today, 5:31 PM
Headset co-founder and CEO Cy Scott says the future of the cannabis industry could look a lot like consumer packaged goods.

LFLY

Read More
1 minute read
  • Cannabis
  • Markets
  • News
  • Psychedelics

Compass Pathways Partners With One Mind To Fund Rising Star Awards

By Fermin Orgambide
Today, 5:31 PM
Compass Pathways plc (NASDAQ:CMPS) and California-based non-profit organization One Mind partnered to sponsor three “2022 One Mind - COMPASS Rising Stars Awards.”

CMPS

Read More
1 minute read
  • Cannabis
  • Markets
  • News

Irwin Naturals And Hive Laboratory: Licensing Agreement For Branded THC Products In California

By Fermin Orgambide
Today, 5:31 PM
Irwin Natural’s (OTCQB: IWINF) Irwin Naturals Cannabis, Inc., entered into a licensing agreement with California-based The Hive Laboratory, LLC, which will produce and distribute some of Irwin Naturals’ formulas, such as Power to Sleep, which is augmented with THC.

IWINF

Read More
3 minute read
  • Cannabis
  • Events
  • Exclusives
  • General
  • Markets
  • News
  • Politics
  • Small Cap

EXCLUSIVE: Why This Cannabis Finance Exec Fears The SAFE Banking Act May Not Survive In Present Form

By Fermin Orgambide
Today, 5:31 PM
Leonard Tannenbaum, founder, chairman and CEO of AFC Gamma Inc (NASDAQ: AFCG), does not hold much hope the SAFE Banking Act will pass into law this year

AFCG

Read More
2 minute read
  • Cannabis
  • Entertainment
  • General
  • Markets
  • News
  • Psychedelics

Jaden Smith Wants To Be A ‘Psychedelics World Leader’ After Trying Magic Mushrooms

By Fermin Orgambide
Today, 5:31 PM
In an interview with Complex to promote his clothing brand MSFTSrep, Jaden Smith talked about his experience with psychedelics and said he is looking to be a “psychedelics world leader.”

ATAI

Read More
2 minute read
  • Cannabis
  • General
  • Health Care
  • Markets
  • News
  • Psychedelics

Irwin Naturals Adds Five Ketamine Facilities Toward Goal To Become World’s Largest Mental Health Treatment Chain

By Fermin Orgambide
Today, 5:31 PM
With the goal of becoming the world’s largest chain of psychedelic mental health clinics, Irwin Naturals Inc. (OTCQB: IWINF) announced the acquisition of five ketamine treatment clinics in Florida and a partnership contract with two clinics in Mexico.

IWINF

Posts navigation

Previous 1 2 3 4 … 6 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service